These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7094417)

  • 21. Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis.
    Wassermann NH; Penn AS; Freimuth PI; Treptow N; Wentzel S; Cleveland WL; Erlanger BF
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4810-4. PubMed ID: 6181515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-acetylcholine receptor antibody related idiotypes in myasthenia gravis.
    Lefvert AK
    J Autoimmun; 1988 Feb; 1(1):63-72. PubMed ID: 3267109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemical analysis of acetylcholine receptor and its relevance to specific treatment of experimental autoimmune myasthenia gravis.
    Fuchs S
    Adv Cytopharmacol; 1979; 3():279-85. PubMed ID: 382790
    [No Abstract]   [Full Text] [Related]  

  • 24. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies.
    Roberts A; Lang B; Vincent A; Newsom-Davis J
    Autoimmunity; 1992; 12(1):53-60. PubMed ID: 1617105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism.
    Wall KA; Hu JY; Currier P; Southwood S; Sette A; Infante AJ
    J Immunol; 1994 May; 152(9):4526-36. PubMed ID: 8157967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylcholine receptor antibodies and anti-idiotypic antibodies produced in blood lymphocyte cultures from patients with myasthenia gravis.
    Lefvert AK; Sundén H; Holm G
    Scand J Immunol; 1986 Jun; 23(6):655-62. PubMed ID: 3715409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis.
    Li J; Qi H; Tüzün E; Allman W; Yilmaz V; Saini SS; Deymeer F; Saruhan-Direskeneli G; Christadoss P
    J Neuroimmunol; 2009 Mar; 208(1-2):40-5. PubMed ID: 19193448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of autoimmune reactivity against acetylcholine receptor with idiotype-specific immunotoxins.
    Krolick KA
    Methods Enzymol; 1989; 178():448-55. PubMed ID: 2601628
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-ligand antibodies as potential autoantigens: in vitro and in vivo characteristics of anti-bungarotoxin antibodies in the idiotype network.
    Pachner AR; Itano AA; McCallum RM; Ricalton NS
    Autoimmunity; 1991; 10(2):145-52. PubMed ID: 1782327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.
    Krolick KA; Yeh TM; Edlund SA
    Cell Immunol; 1996 Aug; 172(1):10-20. PubMed ID: 8806801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pros and cons of treating murine myasthenia gravis with anti-C1q antibody.
    Tüzün E; Li J; Saini SS; Yang H; Christadoss P
    J Neuroimmunol; 2007 Jan; 182(1-2):167-76. PubMed ID: 17137637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The main immunogenic region of acetylcholine receptors does not provoke the formation of antibodies of a predominant idiotype.
    Killen JA; Hochschwender SM; Lindstrom JM
    J Neuroimmunol; 1985 Aug; 9(3-4):229-41. PubMed ID: 4019748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis.
    Huang D; Shi FD; Giscombe R; Zhou Y; Ljunggren HG; Lefvert AK
    Eur J Immunol; 2001 Jan; 31(1):225-32. PubMed ID: 11265638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes.
    Souroujon MC; Barchan D; Fuchs S
    Immunol Lett; 1985; 9(6):331-6. PubMed ID: 3874156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of experimental myasthenia gravis in rhesus monkeys: a model for the study of the human disease.
    Toro-Goyco E; Cora EM; Kessler MJ; Martinez-Carrion M
    P R Health Sci J; 1986 Apr; 5(1):13-8. PubMed ID: 3797623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
    Okumura S; McIntosh K; Drachman DB
    Ann Neurol; 1994 Nov; 36(5):704-13. PubMed ID: 7979216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.